Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,686.0
33.1 (1.25%)

 

  • STI Straits Times Index
    2,686.0
    33.1 (1.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,226.4
    853.3 (3.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,324.4
    171.6 (5.44%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,714.4
    408.0 (1.83%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 935.5M
  • Value: 614.1M
  • Rise: 227
  • Fall: 73
  • Unch: 508

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.120+0.005
Rex Intl0.186+0.006
Medtecs Intl0.595+0.095
LionGold0.002-
Yoma Strategic0.320+0.005
Synagie0.197+0.006
Spackman0.010-
ThaiBev0.715+0.020
MDR0.001-
AnAn Intl0.070+0.006

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PEIJIA-B PEIJIA-B
Quotes 15 Minutes Delayed. Updated at 06 Jul 2020 14:19
Last (HKD): 33.700 Change: -0.950 High: 35.200 Remarks: -
Change (%): -2.74 Low: 33.600
Open 34.800 Yesterday's Close 34.650
Buy Price 33.750 Sell Price 33.800
Buy Volume ('000) 3 Sell Volume ('000) 9
Cumulative Volume ('000) 1,936 Cumulative Value 66,069,500
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.84051 Trailing EPS (HKD) e -0.84051 NAV (HKD) b -0.8820
PE a - Trailing PE f - Price / NAV b -38.2086
Dividend (HKD) d - Cash In Hand (HKD) g 0.7973 Issued & Paid-up Shares c 632,918,000
Dividend Yield (%) d - Price / Cash In Hand g 42.268 Treasury Shares h -
Beta - 75 Daysi 0.123 R-Squared - 75 Days(%)i 0.01 Market Cap (M) 21,329.337
Beta - 500 Daysi 0.037 R-Squared - 500 Days (%)i - Enterprise Value (M) 22,174.381
Piotroski F Score 3 Exchange Code 9996 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 79.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 07 May 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PEIJIA-B HKEx 21,329.337 - - -38.2086 -
Industry Medical Specialties HKEx 17,135.247 108.967 108.967 6.5741 0.296
Local Peer WEIGAO GROUP HKEx 83,753.552 40.036 40.036 4.6261 0.716
Local Peer MICROPORT HKEx 60,564.336 167.015 167.018 14.9759 0.142
Local Peer KANGJI MEDICAL HKEx 38,505.457 186.522 186.518 117.6808 -
Local Peer VENUS MEDTECH-B HKEx 32,943.992 - - 9.6976 -
Local Peer AK MEDICAL HKEx 28,517.632 94.197 94.196 22.8449 0.277
Local Peer KDL MEDICAL HKEx 11,288.000 99.934 99.935 8.2961 0.287
Local Peer LIFETECH SCI HKEx 10,026.350 68.437 68.438 7.7809 -
Local Peer CIRC HKEx 7,133.208 19.119 19.119 1.6963 0.685
Local Peer YESTAR HEALTH HKEx 2,921.642 12.713 12.713 2.2274 -
Local Peer PW MEDTECH HKEx 2,589.262 27.853 27.853 0.5023 -
Local Peer GOLDEN MEDITECH HKEx 2,304.375 - - 0.5993 -
Local Peer MODERN DENTAL HKEx 1,393.425 8.625 8.625 0.6895 3.678
Other Local Peers VINCENT MED (HKEx), YUNNAN ENERGY (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), HAEMONETICS CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), SUPERMX (Bursa), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.500
-4.26 %
10 Days -+2.450
+7.84 %
20 Days -+6.450
+23.67 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 24.600 - 37.800 Change From 1 Year Low +9.100 % Change From 1 Year Low (%) +36.99
Change From 1 Year High -4.100 % Change From 1 Year High (%) -10.85
2 Years Range 24.600 - 37.800 Change From 2 Years Low +9.100 % Change From 2 Years Low (%) +36.99
Change From 2 Years High -4.100 % Change From 2 Years High (%) -10.85
5 Years Range 24.600 - 37.800 Change From 5 Years Low +9.100 % Change From 5 Years Low (%) +36.99
Change From 5 Years High -4.100 % Change From 5 Years High (%) -10.85
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. It operates through the Transcatheter Valve Therapeutic Business and Neurointerventional Business segments. The Transcatheter Valve Therapeutic Busines segment offers transcatheter devices for aortic, mitral and tricuspid valves. The Neurointerventional Business segment deals with the research and development of neurointerventional procedural medical devices. The company was founded by Yi Zhang, Ping Ye Zhang, and Hong Ye on May 30, 2012 and is headquartered in Suzhou, China.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 34.500 35.550 33.300 34.650 2,355,400 34.5167
02 Jul 2020 35.800 36.400 34.050 34.300 3,121,113 35.1778
30 Jun 2020 36.500 37.800 35.000 35.100 3,461,726 36.1991
29 Jun 2020 35.000 35.800 33.400 35.800 2,766,213 34.3142
26 Jun 2020 33.900 36.000 33.750 35.200 3,417,362 35.3379
24 Jun 2020 31.600 34.150 31.000 33.850 4,530,602 33.0499
23 Jun 2020 31.600 31.600 30.500 31.600 1,727,034 31.0250
22 Jun 2020 32.000 32.100 31.150 31.250 1,142,867 31.6916
19 Jun 2020 31.800 32.150 31.250 31.250 1,916,000 31.6654
18 Jun 2020 31.350 32.300 31.000 31.700 2,869,590 31.7190
17 Jun 2020 31.050 32.200 30.350 31.600 1,678,000 31.5758
16 Jun 2020 32.000 33.500 31.000 31.100 4,711,011 32.2868
15 Jun 2020 29.500 31.600 29.500 31.500 7,484,564 30.9734
12 Jun 2020 27.800 29.700 27.750 29.500 3,301,000 29.2242
11 Jun 2020 27.400 28.800 27.300 28.650 7,356,318 28.3770
10 Jun 2020 26.850 27.800 26.750 27.400 1,816,000 27.3517
09 Jun 2020 26.550 27.500 26.300 26.950 1,705,343 27.0602
08 Jun 2020 27.200 27.400 26.500 26.550 1,080,100 26.7902
05 Jun 2020 26.800 27.450 26.300 27.250 1,331,000 26.9431
04 Jun 2020 27.400 27.450 26.500 26.800 1,569,000 26.7953
03 Jun 2020 27.050 27.550 27.000 27.200 1,878,560 27.2548
02 Jun 2020 26.800 27.450 26.150 26.800 2,466,000 26.9078
Summary
Current 2 Weeks
(18 Jun 2020 to 03 Jul 2020)
31.350 37.800 30.500 34.650 27,307,907 -
Previous 2 Weeks
(04 Jun 2020 to 17 Jun 2020)
27.400 37.800 26.500 31.600 32,032,336 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.